SE8305217D0 - Carbapenem antibiotics - Google Patents

Carbapenem antibiotics

Info

Publication number
SE8305217D0
SE8305217D0 SE8305217A SE8305217A SE8305217D0 SE 8305217 D0 SE8305217 D0 SE 8305217D0 SE 8305217 A SE8305217 A SE 8305217A SE 8305217 A SE8305217 A SE 8305217A SE 8305217 D0 SE8305217 D0 SE 8305217D0
Authority
SE
Sweden
Prior art keywords
aliphatic
heterocyclyl
cycloaliphatic
substituent
image
Prior art date
Application number
SE8305217A
Other languages
Swedish (sv)
Other versions
SE8305217L (en
SE461734B (en
Inventor
C U Kim
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8305217D0 publication Critical patent/SE8305217D0/en
Publication of SE8305217L publication Critical patent/SE8305217L/en
Publication of SE461734B publication Critical patent/SE461734B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs

Abstract

Disclosed are novel carbapenem derivatives characterized by a 2-substituent of the formula <IMAGE> in which A represents a C1-C6 straight or branched chain alkylene group; R<5> represents an optionally substituted aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aryl, araliphatic, heteroaryl, heteroaraliphatic, heterocyclyl or heterocyclyl-aliphatic radical and <IMAGE> represents a nitrogen-containing aromatic heterocycle attached to the alkylene group A at a ring carbon atom and quaternized by substituent R<5>. Such derivatives are useful as potent antibacterial agents.
SE8305217A 1982-09-28 1983-09-27 NEW CARBAPENEM ANTIBIOTICS AND PROCEDURES FOR PREPARING THEREOF SE461734B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42575582A 1982-09-28 1982-09-28
US53001183A 1983-09-09 1983-09-09

Publications (3)

Publication Number Publication Date
SE8305217D0 true SE8305217D0 (en) 1983-09-27
SE8305217L SE8305217L (en) 1984-03-29
SE461734B SE461734B (en) 1990-03-19

Family

ID=27026797

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305217A SE461734B (en) 1982-09-28 1983-09-27 NEW CARBAPENEM ANTIBIOTICS AND PROCEDURES FOR PREPARING THEREOF

Country Status (29)

Country Link
KR (1) KR890002228B1 (en)
AR (1) AR241785A1 (en)
AT (1) AT382621B (en)
AU (1) AU575541B2 (en)
CA (1) CA1269978A (en)
CH (1) CH656130A5 (en)
CS (1) CS247168B2 (en)
DD (1) DD212255A5 (en)
DE (1) DE3334937A1 (en)
DK (1) DK442383A (en)
ES (1) ES525983A0 (en)
FI (1) FI78094C (en)
FR (1) FR2533568B1 (en)
GB (1) GB2128187B (en)
GR (1) GR78696B (en)
HU (1) HU191066B (en)
IE (1) IE55947B1 (en)
IL (1) IL69824A (en)
IT (1) IT1163944B (en)
LU (1) LU85021A1 (en)
NL (1) NL8303310A (en)
NO (1) NO163284C (en)
NZ (1) NZ205626A (en)
OA (1) OA07548A (en)
PT (1) PT77404B (en)
SE (1) SE461734B (en)
SU (1) SU1493108A3 (en)
YU (1) YU43196B (en)
ZW (1) ZW20783A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683296A (en) * 1983-03-07 1987-07-28 Bristol-Myers Company Carbapenem intermediates
CA1273011A (en) * 1984-07-02 1990-08-21 Susan M. Schmitt Carbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkylthio substituent
CA1273012A (en) * 1984-07-02 1990-08-21 Burton G. Christensen 1-methylcarbapenems having an externally alkylated mono- of bicyclic 2-quarternary heteroarylalkylthio substituent
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4725594A (en) * 1984-12-13 1988-02-16 Merck & Co., Inc. Carbapenems having an internally or externally alkylated mono- or bicyclic 2-quaternary heteroarylalxyl heteromethyl substituent
US4729993A (en) * 1984-12-13 1988-03-08 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkyl substituent
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4880922A (en) * 1985-11-22 1989-11-14 Bristol-Myers Company Carbapenems with quaternized heterothioalkylthio substitution at position 2
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
DK168047B1 (en) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1R, 5S, 6S) -2-SUBSTITUTED THIO-6-OE (R) -1-HYDROXYETHYLAA-1-METHYL-CARBAPENEM-3-CARBOXYLIC ACID DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, MIXTURES AND PREPARATION
EP0876370A1 (en) 1996-01-12 1998-11-11 Takeda Chemical Industries, Ltd. Carbapenem compounds, their production and use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
PT73791B (en) * 1980-10-17 1983-10-14 Merck & Co Inc Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids
GB2089340B (en) * 1980-10-25 1984-09-19 Beecham Group Ltd -lactam antibiotics their preparation and their use
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
EP0074599A1 (en) * 1981-09-09 1983-03-23 Takeda Chemical Industries, Ltd. 5,6-cis-Carbapenem derivatives, their production and use

Also Published As

Publication number Publication date
NZ205626A (en) 1986-12-05
LU85021A1 (en) 1984-04-24
DK442383D0 (en) 1983-09-27
SE8305217L (en) 1984-03-29
ZW20783A1 (en) 1984-11-28
IL69824A0 (en) 1983-12-30
DE3334937C2 (en) 1991-05-02
GB8325744D0 (en) 1983-10-26
DK442383A (en) 1984-03-29
ATA344983A (en) 1986-08-15
NO163284C (en) 1990-05-02
AT382621B (en) 1987-03-25
FI833417A0 (en) 1983-09-23
DD212255A5 (en) 1984-08-08
GR78696B (en) 1984-09-27
ES8503354A1 (en) 1985-02-16
IT1163944B (en) 1987-04-08
KR890002228B1 (en) 1989-06-24
FI833417A (en) 1984-03-29
HU191066B (en) 1987-01-28
IE55947B1 (en) 1991-02-27
FR2533568A1 (en) 1984-03-30
FI78094B (en) 1989-02-28
SU1493108A3 (en) 1989-07-07
OA07548A (en) 1985-03-31
IL69824A (en) 1991-04-15
NO833479L (en) 1984-03-29
CS247168B2 (en) 1986-12-18
SE461734B (en) 1990-03-19
GB2128187B (en) 1986-06-18
AU1934283A (en) 1984-04-05
YU43196B (en) 1989-04-30
CA1269978A (en) 1990-06-05
DE3334937A1 (en) 1984-04-05
YU190683A (en) 1985-10-31
IE832266L (en) 1984-03-28
FI78094C (en) 1989-06-12
AR241785A1 (en) 1992-12-30
ES525983A0 (en) 1985-02-16
KR840006249A (en) 1984-11-22
GB2128187A (en) 1984-04-26
NL8303310A (en) 1984-04-16
CH656130A5 (en) 1986-06-13
IT8323022A0 (en) 1983-09-27
PT77404B (en) 1986-06-26
FR2533568B1 (en) 1990-01-26
AU575541B2 (en) 1988-08-04
NO163284B (en) 1990-01-22
PT77404A (en) 1983-10-01

Similar Documents

Publication Publication Date Title
SE8303502D0 (en) Carbapenem antibiotics
DK518683D0 (en) PROCEDURE FOR THE PREPARATION OF 4 &#34;EPI-9-DEOXO-9A-METHYL-9A-AZA-9A-HOMOERYTHROMYCINE OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS AND INTERMEDIATES OF THE PROCEDURE
SE8502017L (en) 1,4-DIHYDRO-4-OXONAFTYRIDINE DERIVATIVES AND SALTS THEREOF, PROCEDURE FOR PREPARING THESE EASY ANTI-BACTERIAL AGENTS INCLUDING THESE
SE8305217L (en) Carbapenem antibiotics
FI864825A (en) CEFALOSPORINDERIVAT.
ATE110081T1 (en) CEPHALOSPORIN DERIVATIVES WITH LOCATION 3 A THIOALKYLTHIO GROUP.
NZ217650A (en) Quinoline derivatives and pharmaceutical compositions
SE8301929L (en) NEW CARBAPEN NAME DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND NEW INTERMEDIATES FOR USE IN THESE PROCEDURES
HRP931480A2 (en) 9a-N-(N&#39;-CARBAMONYL) and 9a-N-(N&#39;-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
MX9301361A (en) ANTIMICROBIAL CARBAPENEMA DERIVATIVES AND THEIR PREPARATION.
GR3004658T3 (en)
ES8405399A1 (en) Carbapenem antibiotics
SE8504538D0 (en) CARBAPENEM ANTIBIOTICS
SE8604990D0 (en) CARBAPENEMS WITH QUATERNIZED HETEROTHIOALKYLTHIO SUBSTITUTION AT POSITION 2
ATE119907T1 (en) THIADIAZOLYLACETAMIDE CEPHEM DERIVATIVES.
ES482550A1 (en) Cephalosporin compounds

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8305217-5

Effective date: 19940410

Format of ref document f/p: F